46.76
0.48%
0.175
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Stock Position Increased by Jennison Associates LLC - MarketBeat
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - MSN
Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's is How to Trade - Yahoo Finance
22,493 Shares in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Purchased by GSA Capital Partners LLP - MarketBeat
What is Lifesci Capital's Forecast for TARS FY2024 Earnings? - MarketBeat
Tarsus Pharmaceuticals Appoints Kate Goodrich, MD, to its Board of Directors - Vision Monday
US$65.33That's What Analysts Think Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Is Worth After These Results - Simply Wall St
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Down 5.3%Here's What Happened - MarketBeat
Midday Stock Roundup: Viant Tech Up Since Q3 Earnings - Orange County Business Journal
Trend Tracker for (TARS) - Stock Traders Daily
Tarsus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
The Goldman Sachs Group Forecasts Strong Price Appreciation for Tarsus Pharmaceuticals (NASDAQ:TARS) Stock - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q3 2024 Earnings Call Transcript - Insider Monkey
Tarsus Pharmaceuticals stock target upgraded, holds buy on strong sales By Investing.com - Investing.com UK
Paradigm Biocapital Advisors LP Increases Stake in Tarsus Pharma - GuruFocus.com
Prudential Financial Inc's Strategic Acquisition in Tarsus Pharm - GuruFocus.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Hits New 1-Year High After Analyst Upgrade - Defense World
Tarsus Pharmaceuticals stock soars to 52-week high of $52 - Investing.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Reaches New 52-Week High After Analyst Upgrade - MarketBeat
Tarsus Pharmaceuticals stock soars to 52-week high of $52 By Investing.com - Investing.com UK
Tarsus Pharmaceuticals (NASDAQ:TARS) Given New $65.00 Price Target at Oppenheimer - MarketBeat
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue Estimates - MSN
Tarsus Pharmaceuticals Inc (TARS) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... - Yahoo Finance
Tarsus Pharmaceuticals Reports Strong Q3 2024 Performance - TipRanks
Tarsus Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Tarsus Pharmaceuticals Inc (TARS) Q3 2024 Earnings: EPS of $(0.6 - GuruFocus.com
Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements - GlobeNewswire
Tarsus Pharmaceuticals appoints new board member By Investing.com - Investing.com Canada
Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors - The Manila Times
Tarsus Pharma Strengthens Board with Humana CMO Dr. Kate Goodrich Appointment | TARS Stock News - StockTitan
Jennison Associates LLC Increases Stake in Tarsus Pharmaceuticals Inc - GuruFocus.com
Tarsus Pharmaceuticals Appoints Elizabeth Yeu, MD, as Chief Medical Officer - Vision Monday
Lisanti Capital Growth LLC Takes $1.31 Million Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals seesaws amid report Alcon interest has cooled - MSN
Creative Planning Makes New Investment in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals (TARS) to Release Quarterly Earnings on Wednesday - MarketBeat
Creative Planning Takes Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Investors Appear Satisfied With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Prospects As Shares Rocket 41% - Simply Wall St
Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 - GlobeNewswire
Tarsus Pharmaceuticals stock hits 52-week high at $48.65 - Investing.com
Tarsus Pharmaceuticals stock hits 52-week high at $48.65 By Investing.com - Investing.com UK
Tarsus Pharmaceuticals Inc (TARS-Q) QuotePress Release - The Globe and Mail
Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer - GlobeNewswire
Tarsus Pharmaceuticals appoints new Chief Medical Officer - Investing.com India
Tarsus Pharmaceuticals appoints new Chief Medical Officer By Investing.com - Investing.com South Africa
Papulopustular Rosacea Market to Expand Significantly by 2034, States DelveInsight Report | Sol-Gel Technologies, Galderma, CollaGenex Pharma, Tarsus Pharma, Pfizer - Barchart
Papulopustular Rosacea Market to Expand Significantly by 2034, - openPR
Tarsus Pharma Names Leading Ophthalmologist Dr. Elizabeth Yeu as New Chief Medical Officer | TARS Stock News - StockTitan
Here's Why Tarsus Pharmaceuticals (NASDAQ:TARS) Can Manage Its Debt Despite Losing Money - Simply Wall St
Vanguard Group Inc's Strategic Acquisition in Tarsus Pharmaceuti - GuruFocus.com
Emerald Advisers LLC Takes Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 8.5% HigherShould You Buy? - MarketBeat
Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains? - MSN
Tarsus Pharmaceuticals stock hits 52-week high at $42.63 By Investing.com - Investing.com Australia
자본화:
|
볼륨(24시간):